Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cetek Corporation and Essential Therapeutics Have Entered Into a New Screening Agreement.


Business/Technology Editors & Health/Medical Writers

BIOWIRE2K

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Aug. 21, 2002

Cetek Corporation announced today that it has entered into a screening agreement with Essential Therapeutics, Inc. The two companies entered into a previous agreement in June 2001.

Essential Therapeutics will utilize Cetek's high-throughput screening High-throughput screening (HTS), is a method for scientific experimentation especially used in drug discovery and relevant to the fields of biology and chemistry. Purpose and method  technology to discover novel antibiotics for Essential Therapeutics and its partner, Fujisawa Pharmaceutical Co., Ltd.

"We began working with Cetek a year ago and their CE Assay has proven very efficient and effective in finding early lead candidates from both synthetic and natural extract libraries" said George H. Miller George H. Miller Ph.D. was appointed the interim director of the Lawrence Livermore National Laboratory (LLNL) by the University of California on March 15, 2006. Dr. Miller, an employee of the university for 34 years, replaced Michael Anastasio, who left LLNL to head Los Alamos , Ph.D., Executive Vice President of Essential Therapeutics.

"We are very pleased that Essential has once again demonstrated confidence in our proprietary technology by selecting us to provide screening in their new relationship involving Fujisawa, " said James N. Little, Ph.D., President of Cetek.

Cetek Corporation is a drug discovery company that is unlocking new reservoirs of natural compound diversity for the creation of novel therapeutics. Cetek integrates expertise in automation, engineering and novel strategies in natural product chemistry to utilize its capillary electrophoresis Capillary electrophoresis (CE), also known as capillary zone electrophoresis (CZE), can be used to separate ionic species by their charge and frictional forces. In traditional electrophoresis, electrically charged analytes move in a conductive liquid medium under the  (CE) technology as a highly sensitive Adj. 1. highly sensitive - readily affected by various agents; "a highly sensitive explosive is easily exploded by a shock"; "a sensitive colloid is readily coagulated"  and robust technology for high throughput screening and compound isolation. Cetek also employs its automated CE Assay(TM) to provide contract research for pharmaceutical and biotechnology partners to advance their own synthetic and natural product drug discovery programs. Cetek has collaborations with pharmaceutical and biotechnology companies Top 100 Biotechnology Companies
The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies.
 in North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. , Europe and Japan.

For additional information, visit Cetek's website at http://www.cetek.com or contact Dr. James N. Little, President, at (508) 229-8900 or j.little@cetek.com.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:Cetek Corporation and Essential Therapeutics Have Entered Into a New Screening Agreement.
Publication:Business Wire
Geographic Code:1USA
Date:Aug 21, 2002
Words:265
Previous Article:Nextel Unveils Wireless Business Solutions Initiative; Business Communications Leader Pioneers Advancements for the Real-Time Enterprise.
Next Article:ADVISORY/Chicago Hotel Workers March on Magnificent Mile.



Related Articles
Cetek Secures $14 Million in Private Funding to Build Natural Product Drug Discovery Engine.
Cetek Secures $14 Million in Private Funding to Build Natural Product Drug Discovery Engine.
Cetek to Develop Assays and High Throughput Screens for Lexicon Genetics' Novel in vivo Validated Targets.
Cetek Corporation Announces Several Promotions Including James N. Little, Ph.D. to President; Cetek to Present at the J.P. Morgan H&Q Conference.
Cetek and Cubist Expand Research Collaboration to Include Natural Product Drug Discovery.
Cetek Announces Agreement with Tularik for Assay Development and High Throughput Screening.
Cetek Corporation Achieves Research Milestone Payment From Millennium Pharmaceuticals.
Cetek Corporation and Pharmacia Sign New Multi-Year Research Agreement.
EXONHIT INITIATES PHASE II CLINICAL TRIAL FOR EHT 0201.
BIOCRYST/GREEN CROSS TO DEVELOP PERAMIVIR IN SOUTH KOREA.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles